Forecasts data is unavailable for this security.
Consensus recommendation
- 18-May-23
- 15-Feb-24
- 14-Mar-24
- 18-Apr-24
- 09-May-24
Select bar for recommendation details.
Recommendations | 09-May-24 | |
---|---|---|
Buy | 10 | |
Outperform | 9 | |
Hold | 10 | |
Underperform | 0 | |
Sell | 0 |
Share price forecast in CNY
The 23 analysts offering 12 month price targets for WuXi Biologics (Cayman) Inc have a median target of 20.99, with a high estimate of 61.95 and a low estimate of 11.99. The median estimate represents a 43.15% increase from the last price of 14.66.
High | 322.6% | 61.95 |
Med | 43.1% | 20.99 |
Low | -18.2% | 11.99 |
Earnings history & estimates in CNY
Average growth rate | +40.68% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +46.04% |
More ▼